Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with polycystic ovary syndrome may have a higher risk of heart problems due to abnormal nervous system control of their heart and blood pressure.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.